Related Experiment Video
Updated: Jan 25, 2026

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Patient Blood Management for Neonates and Children Undergoing Cardiac Surgery: 2019 NATA Guidelines
David Faraoni1, Jens Meier2, Helen V New3
1Division of Cardiac Anesthesia, Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Insights
Patient blood management (PBM) is crucial for pediatric cardiac surgery to reduce bleeding and blood product use. Specific guidelines are needed for children, as current evidence is limited, to improve patient outcomes.
Area of Science:
- Cardiovascular Surgery
- Hematology
- Pediatric Critical Care
Background:
- Pediatric cardiac surgery carries a high risk of bleeding, often necessitating allogeneic blood transfusions.
- Existing patient blood management (PBM) guidelines primarily focus on adults, with limited specific evidence for pediatric cardiac surgery.
- A gap exists in dedicated guidelines for implementing PBM in neonates and children undergoing cardiac procedures.
Purpose of the Study:
- To develop evidence-based recommendations for anemia management and blood transfusion practices in pediatric cardiac surgery.
- To address the lack of specific guidelines for PBM in this vulnerable patient population.
- To identify research gaps in pediatric cardiac PBM.
Main Methods:
- A task force from the Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis (NATA) was convened.
- The task force aimed to synthesize existing evidence and provide expert recommendations.
- Focus on perioperative care of neonates and children undergoing cardiac surgery.
Main Results:
- Current evidence for PBM implementation in pediatric cardiac surgery is mainly from systematic reviews.
- Specific, comprehensive guidelines for this population are currently unavailable.
- The need for optimized hemoglobin, reduced blood sampling, improved hemostasis, and blood-sparing techniques is highlighted.
Conclusions:
- Evidence-based recommendations are needed to guide PBM in pediatric cardiac surgery.
- Implementing PBM strategies can potentially reduce allogeneic blood product administration.
- Further research is essential to refine PBM protocols for neonates and children undergoing cardiac surgery.
Abstract:
Pediatric cardiac surgery is associated with a substantial risk of bleeding, frequently requiring the administration of allogeneic blood products. Efforts to optimize preoperative hemoglobin, limit blood sampling, improve hemostasis, reduce bleeding, correct coagulopathy, and incorporate blood sparing techniques (including restrictive transfusion practices) are key elements of patient blood management (PBM) programs, and should be applied to the pediatric cardiac surgical population as across other disciplines. Many guidelines for implementation of PBM in adults undergoing cardiac surgery are available, but evidence regarding the implementation of PBM in children is limited to systematic reviews and specific guidelines for the pediatric cardiac population are missing. The objective of the task force from the Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis (NATA, www.nataonline.com) is to provide evidence-based recommendations regarding anemia management and blood transfusion practices in the perioperative care of neonates and children undergoing cardiac surgery, and to highlight potential areas where additional research is urgently required.
More Related Videos
07:14A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
04:36Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
SI Units: 2019 Redefinition
A standard set of units has been defined...
Cardiac Catheterization IV: Nursing Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Guidelines for Nursing Documentation II
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
Legal Guidelines for Documentation